PT-141 (Bremelanotide)
$39.75
Cyclic α-MSH analog · Research Use Only
Fast, Dependable Fulfillment.
Orders are processed promptly and shipped within 48 hours of purchase and successful
payment confirmation — because your research shouldn’t wait on us
Research Use Only.
This compound is supplied strictly for in vitro research purposes. It is not approved by the FDA and is not intended for human consumption, therapeutic, diagnostic, or veterinary use. By purchasing, you confirm you are a qualified researcher aged 18+.
- HPLC Verified
- COA Included
- For 21+ Only
- US Sourced
PT-141 is a synthetic heptapeptide analog of α-MSH functioning as a melanocortin receptor agonist, with selective activity at MC3R and MC4R. (Note: this compound, as bremelanotide/Vyleesi, is FDA-approved for a specific clinical indication in premenopausal women — separate context from RUO research supply.)
Research focus: Research has focused on melanocortin receptor pharmacology (binding affinity at MC3R/MC4R) and central nervous system-mediated sexual-response behaviors in rodent and primate models, including measurements of receptivity behaviors and correlated changes in circulating oxytocin.
Specifications
Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Molecular formula: C₅₀H₆₈N₁₄O₁₀
Molecular weight: ~1,025.18 g/mol
CAS: 189691-06-3
Purity: ≥99% (HPLC verified)
Form: Lyophilized powder
For laboratory research use only. Not for human or veterinary use, diagnosis, treatment, or consumption. Not evaluated by the FDA.
You may also research
Related Compounds
Reviews
There are no reviews yet.